Airoldi et al.94 reported that IL-30 expression is similarly elevated in breast cancer patients, particularly those with triple-negative HER2+ subtypes, and that analogous to prostate cancers, IL-30 is found in inflammatory leukocytes infiltrating tumors and the draining lymph nodes, and its expression correlates with the stage of the disease. This evidence concerns the gene IL27 and prostate cancer.